about
Plant derived substances with anti-cancer activity: from folklore to practiceNon-smoker exposure to secondhand cannabis smoke. I. Urine screening and confirmation resultsEvaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal CannabisRisks associated with the non-medicinal use of cannabisThe K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways.CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawalIs cannabis use associated with less opioid use among people who inject drugs?Medicinal Cannabis: In Vitro Validation of Vaporizers for the Smoke-Free Inhalation of Cannabis.Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum.Marijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Endo-cannabinoids system and the toxicity of cannabinoids with a biotechnological approach.Pyrimidinyl Biphenylureas: Identification of New Lead Compounds as Allosteric Modulators of the Cannabinoid Receptor CB1.An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain From Spinal Cord Injury and Disease.Building smart cannabis policy from the science up.Chronic Δ(9)-Tetrahydrocannabinol Administration Reduces IgE(+)B Cells but Unlikely Enhances Pathogenic SIVmac251 Infection in Male Rhesus Macaques of Chinese Origin.Self-medication of achalasia with cannabis, complicated by a cannabis use disorder.Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on MigraineCharacterization of the intrinsic activity for a novel class of cannabinoid receptor ligands: Indole quinuclidine analogs.Limited range of indications for cannabis.Scientific data are lacking.Dronabinol Is a Safe Long-Term Treatment Option for Neuropathic Pain Patients.Δ9-Tetrahydrocannabinol Induces Endocannabinoid Accumulation in Mouse Hepatocytes: Antagonism by Fabp1 Gene Ablation.The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.Systematic review and meta-analysis of cannabinoids in palliative medicine.Cannabis and Kratom online information in Thailand: Facebook trends 2015-2016.Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy.
P2860
Q26781498-F21EE0B0-ED8B-4082-B376-72EF9031C66AQ28249957-1390DCE3-B72C-461D-A29E-274A429E3739Q28834098-EA24E623-88ED-409B-B426-3BDC37AC1D7BQ30316580-95B79472-5B72-41C1-A560-D5B4070CA531Q33908169-59A66DF0-35B1-4B81-8AF9-3D2D3EB02ECFQ33944014-FD112988-6550-42C5-89EE-738BF43BAD88Q34186015-B815AFF5-61D5-41CC-89D1-6AE549A7CFDDQ34194009-F572A767-9D11-4B53-B50E-B8F412D1CB1CQ34403197-93644857-406B-477B-8650-376A09D74F28Q35875597-7E0A5692-DBC9-4522-8825-6830ED423A73Q36479118-400EE8AF-886F-41D6-BB59-52B3BD5B2499Q37373130-128AC8E7-9A41-4728-A6E6-57E8268A2D06Q37512670-0263EB34-825F-4EBF-AFDA-1F1D5B6DC0B2Q38615088-E456E964-8F55-415A-81C6-97E6BEBBA823Q38774127-F0441030-5213-4DC3-98E6-CFDF07F99B51Q38855100-604F6E79-FEA5-4AC2-A61C-5E8C87D58843Q39131734-29FA8A09-6E21-4B5B-89E3-B17CFA602BCDQ40701297-E29B9BD3-AA91-4AB9-83ED-3A778AC241B7Q40879016-54356553-675B-430D-81B1-80A69CFD8397Q41572995-8323FFD6-D797-4706-86A7-61E57AA26D2CQ43214296-C576E764-1294-4732-876B-6DEF024501F3Q43217446-7EACCB1C-D248-40C6-97D0-00C8E9C5B724Q43217450-F6BB67C5-1C91-4F63-A217-C7EE6098F097Q50090308-058C5336-711E-4F0F-B92C-D803145B2937Q50134192-14321A75-6A9A-460B-9CA6-B6332E6D4AEDQ50142905-8F48943C-BA6A-4237-B7AC-8E373833F147Q50201189-69607B40-FD54-43C4-B941-989B661F6913Q53823799-1122A11B-0F1E-4DAE-B4DB-DF79028706ACQ55340197-6E654194-2F75-45E5-96EB-92AFE3F058D4
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The therapeutic potential of cannabis and cannabinoids
@ast
The therapeutic potential of cannabis and cannabinoids
@en
The therapeutic potential of cannabis and cannabinoids
@nl
type
label
The therapeutic potential of cannabis and cannabinoids
@ast
The therapeutic potential of cannabis and cannabinoids
@en
The therapeutic potential of cannabis and cannabinoids
@nl
prefLabel
The therapeutic potential of cannabis and cannabinoids
@ast
The therapeutic potential of cannabis and cannabinoids
@en
The therapeutic potential of cannabis and cannabinoids
@nl
P2860
P3181
P1476
The therapeutic potential of cannabis and cannabinoids
@en
P2093
Franjo Grotenhermen
Kirsten Müller-Vahl
P2860
P304
P3181
P356
10.3238/ARZTEBL.2012.0495
P407
P577
2012-07-01T00:00:00Z